Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma

British Journal of Cancer

Volumn 77, Issue 8, 1998, Pages 1253-1259

  Maurizi, M ^a   Ferrandina, G ^a   Almadori, G ^a   Scambia, G ^a   Cadoni, G ^a   D'Agostino, G ^a   Serra, F G ^a   Piantelli, M ^b   Mancuso, S ^a   Ranelletti, F O ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Larynx; MeHPLA esterase activity; Prognosis; Squamous cell carcinoma

Indexed keywords

ESTERASE;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CERVICAL LYMPH NODE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

EID: 6844255873     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.210     Document Type: Article

References (31)

1. Anderson JA, Irish JC and Ngan BY (1992) Prevalence of RAS oneogene mutation in head and neck carcinomas. J Otolaryngol 21: 321-326
2. Bellacosa JA, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G and Neri G (1996) Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin Cancer Res 2: 175-180
3. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN and Sidransky D (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429-435
4. Clark JH, Hardin JW and Upchurch S (1978) Heterogencity of estrogen-binding sites in the cytosol of the rat uterus. J Biol Chem 253: 7630-7634
5. Coltrera MD (1993) The use of cell proliferation markers in tissue sections as indicators of prognosis. In Head and Neck Cancer, Vol. III, Johnson JT and Didolkar MS (eds), pp. 379-384. Elsevier Science: New York
6. Cox DR (1972) Regression models and life tables. J Royal Statist Soc 34: 197-220
7. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F and Milano G (1993) Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11: 1873-1878
8. EORTC (1980) Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515
9. Ferrandina G, Scambia G, Benedetti Panici P, Ranelletti FO, De Vincenzo R, Piantelli M, Distefano M, Capelli A and Mancuso S (1993) Type-II-estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone and epidermal-growth factor receptor. Gynecol Oncol 49: 67-72
10. Griffiths LA and Smith GE (1972) Metabolism of apigenin and related compounds in the rat. Biochem J 128: 901-911
11. Hermanek P and Sobin LH (1992) Larynx. In International Union against Cancer. TNM Classification of Malignant Tumors, 4 edn. pp. 25 28. Springer: Berlin
12. Irish JC and Bernstein A (1993) Oncogenes in head and neck cancer. Laryngoscope 103: 42-52
13. Kaplan E and Meyer P (1958) Non-parametric estimation from incomplete observation. J Am Statist Assoc 53: 457-481
14. Kearseley JH, Bryson G, Battistutta D and Collins RJ (1991) Prognostic importance of cellular DNA content in head- and neck-squamous-cell cancers. A comparison of retrospective and prospective series. Int J Cancer 47: 31-37
15. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170
16. Markaverich BM, Gregory RR, Alejandro MA, Clark JH, Johnson GA and Middleditch BS (1988a). Methyl p-hydroxyphenyllactate. J Biol Chem 263: 7203-7210
17. Markaverich BM, Roberts RR, Alejandro MA, Johnson GA, Middleditch BS and Clark JH (1988b) Bioflavonoid interaction with rat uterine type-II-binding sites and cell-growth inhibition. J Steroid Biochem 30: 71-78
18. Markaverich BM, Gregory RR, Alejandro MA, Varma RS, Johnson GA and Middleditch BS (1989) Estrogen regulation of methyl p-hydroxyphenyllactate hydrolysis: correlation with estrogen stimulation of rat uterine growth. J Steroid Biochem 33: 867-876
19. Markaverich BM, Gregory RR, Alejandro MA, Kittrell FS, Medina D, Clark JH, Varma M and Varma RS (1990) Methyl p-hydroxyphenyllactate and nuclear Type-II-binding sites in malignant cells. Metabolic fate and mammary tumor growth. Cancer Res 50: 1470-1478
20. Maurizi M, Scambia G, Benedetti Panici P, Ferrandina G, Almadori G, Paludetti G, De Vincenzo R, Distefano M, Cadoni G and Mancuso S (1992) EGF receptor in primary squamous laryngeal cancer: correlation with clinico-pathological features and prognostic significance. Int J Cancer 52: 862-866
21. Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti Panici P, Paludetti G, Scambia G and Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74: 1253-1257
22. Miyaguchi M, Olofsson J and Hellquist HB (1990) Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma. Acta Otolaryngol 110: 309-313
23. Piantelli M, Rinelli A, Macri E, Maggiano N, Larocca LM, Scerrati M, Roselli R, Iacoangeli M, Scambia G, Capelli A and Ranelletti FO (1993) Type-II-estrogen-binding sites and anti-proliferative activity of quercetin in human meningiomas. Cancer 71: 193-198
24. Ranelletti FO, Piantelli M, Carbone A, Rinelli A, Scambia G, Benedetti Panici P and Mancuso S (1988) Type-II-estrogen binding sites and 17beta-hydroxysteroid dehydrogenase activity in human peripheral-blood mononuclear cells. J Clin Endocrinol Metab 67: 888-892
25. Ranelletti FO, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambia G, Benedetti Panici P, Mancuso S, Rumi C and Piantelli M (1992) Growth-inhibitory effect of quercetin and presence of type-II-estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer 50: 486-492
26. Ranelletti FO, Scambia G, Benedetti Panici P, Piantelli M, Ferrandina G, D' Agostino G, De Vincenzo R, Rinelli A, Isola G and Mancuso S (1995) Methyl phydroxyphenyllactate esterase activity and type-II estrogen-binding sites in ovarian cancer: correlation with biological and clinico-pathological parameters. Int J Cancer 62: 536-541
27. Rua S, Comino A, Fruttero A, Cera G, Semeria C, Lanzillotta L and Boffetta P (1991) Relationship between histologic features, DNA flow cytometry, and clinical behavior of squamous cell earcinoma of the larynx. Cancer 67: 141-149
28. Santini J, Formento JL, Francouai M, Milano G, Schneider M, Dassonville O and Demard F (1991) Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carinomas. Head Neck 13: 132-139
29. Scambia G, Benedetti Panici P, Battaglia F, Ferrandina G, Almadori G, Paludetti G, Maurizi M and Mancuso S (1991) Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors. Cancer 67: 1347-1351
30. Scambia G, Catozzi L, Benedetti Panici P, Ferrandina G, Almadori G, Paludetti G, Cadoni G, Distefano M, Piffanelli A, Mancuso S and Maurizi M (1994) Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors. Br J Cancer 69: 995-999
31. Snow GB (1989) Evaluation and staging of the patient with head and neck cancer. In Cancer of the Head and Neck, 2nd edn. Myers EN and Suen JY (eds). pp. 17-38. Churchill Livingstone: New York